Evidence map›Paper›PMID 34613876›Full record

ArticleHuman vaccines & immunotherapeutics2021

Tracking the progress in COVID-19 and vaccine safety research - a comprehensive bibliometric analysis of publications indexed in Scopus database.

Tosin Yinka Akintunde, Shaojun Chen, Taha Hussein Musa, Felix Oluseyi Amoo, Adekunle Adedeji, Elhakim Ibrahim, Angwi Enow Tassang, Idriss Hussein Musa, Hassan Hussein Musa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tosin Yinka AkintundeDepartment of Sociology, School of Public Administration, Hohai University, Nanjing, China.ORCID 0000-0002-9392-8726
Shaojun ChenDepartment of Sociology, School of Public Administration, Hohai University, Nanjing, China.
Taha Hussein MusaOrganization of African Academic Doctor (OAAD), Nairobi, Kenya.
Felix Oluseyi AmooOrganization of African Academic Doctor (OAAD), Nairobi, Kenya.
Adekunle AdedejiOrganization of African Academic Doctor (OAAD), Nairobi, Kenya.
Elhakim IbrahimDepartment of Demography and Social Statistics, Faculty of Social Science, Obafemi Awolowo University, Ile-Ife, Nigeria.
Angwi Enow TassangDepartment of Sociology, School of Public Administration, Hohai University, Nanjing, China.
Idriss Hussein MusaOrganization of African Academic Doctor (OAAD), Nairobi, Kenya.
Hassan Hussein MusaOrganization of African Academic Doctor (OAAD), Nairobi, Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 pandemic public health emergency is one of the worse disease outbreaks in the history of infectious disease. The consequence has resulted in over 4 million deaths globally. Therefore, a more in-depth understanding of the dynamics of the disease, vaccine development, and safety has become crucial for the disease eradication.

objectiveThe study adopted bibliometric analysis to identify the global contribution in COVID-19 and Vaccine Safety and analyzed the current status, development, and research hotspots to reference for future research directions.

methodsStudies published between January 1, 2019 and July 11, 2021 were retrieved from the Scopus database. Data analysis and visualization were conducted using VOSviewer ver 1.6.6, Bibliometrix app. (Using R).

resultsA total of 1827 publications with 12.14 average citations per document were identified. These publications were published in 796 journals by 10,243 authors (with 5.61 authors per document) from 80 countries/regions. About 33.75% of the researches were from the developed countries. The USA, China, and India were top contributors for scientific research on COVID-19 and vaccine safety. The "Vaccine" is the most productive journal with 58 articles. Li Y, NA NA, and Liu X were the top three prolific authors. Furthermore, "Human," "Coronavirus disease 2019," and "Drug safety," were the most common frontier topics.

conclusionsOur analysis highlights the characteristics of the most influential articles on COVID-19 related to vaccine safety. The findings provided valuable insight into the scientific research progress in this domain and suggest scaling-up research and information dissemination on COVID-19 and vaccine safety.

Indexed as

COVID-19BibliometricsHumansPandemicsSARS-CoV-2Vaccine DevelopmentbibliometricsCOVID-19Scopus databasevaccine safetyVOSviewer

Identifiers

PMID34613876
PMCPMC8828093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.